Scime, Natalie V.
Metcalfe, Amy
Nettel-Aguirre, Alberto
Nerenberg, Kara
Seow, Cynthia H.
Tough, Suzanne C.
Chaput, Kathleen H.
Funding for this research was provided by:
Canadian Institutes of Health Research (Canada Graduate Scholarship Doctoral Award)
University of Calgary Department of Pediatrics
Alva Foundation
Article History
Received: 27 November 2022
Accepted: 25 January 2023
First Online: 2 February 2023
Declarations
:
: The MaCI study was approved by the Conjoint Health Research Ethics Board at the University of Calgary (REB19-0443), and all participants provided informed consent upon enrollment. All methods were performed in accordance with relevant guidelines and regulations from the Declarations of Helsinki and the Tri-Council Policy Statement on Research Ethics.
: Not applicable.
: CHS has served on advisory boards for Janssen, AbbVie, Takeda, Ferring, Shire, Pfizer, Sandoz, Pharmascience, Fresenius Kabi and Amgen, and as a speaker for Janssen, AbbVie, Takeda, Ferring, Shire, Pfizer and Pharmascience. NVS, AM, ANA, KN, SCT, and KHC have no potential conflicts of interest to report.